Cara Anthony tries to convince her HealthQ co-host Blake Farmer that there are benefits to embracing the caregiver identity when helping an aging parent. (Candice Evers for WPLN and KFF Health News) When his father was diagnosed with gallbladder cancer in 2025, William Morrison immediately went into caregiving mode. “We were in the hospital every
Health 11 September 2020 By Jessica Hamzelou Researchers have found cases of people being infected with the coronavirus a second time NR Med/Brin Reynolds In recent weeks, the first confirmed reports of people who have been reinfected with the coronavirus have begun to trickle in. Such cases suggest that, in some people at least, the…
KwaZulu-Natal Premier Sihle Zikalala. Supplied by KZN Health Dept KwaZulu-Natal's numbers were predicted to be around 200 000 cases by mid-July, but is only around 23 000 now.There is, however, still cause for concern after nearly 10 000 cases and 182 deaths were recorded last week alone.The province is currently on a surge, with 1…
New survey shows 7 in 10 Americans agree 2020 is the lowest point in the country’s history that they’ve witnessed Two-thirds say that the government’s response to the coronavirus is a source of daily stress for them WASHINGTON — The year 2020 feels like a crossroads for the United States. With a pivotal election just around…
The COVID-19 pandemic hasn’t stopped big crowds from taking to San Francisco’s streets to protest police violence in recent days, so city officials have set up a mobile testing site for people concerned about exposure to the coronavirus. A free, pop-up testing location at the Cathedral of St. Mary at 1111 Gough St. opened at…
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.
You don't have permission to access "http://www.medpagetoday.com/washington-watch/washington-watch/123652" on this server. Reference #18.d494d817.1793332899.22e6a54f https://errors.edgesuite.net/18.d494d817.1793332899.22e6a54f